Article Details
Retrieved on: 2018-01-03 23:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Dr. Moller brings a long history of experience in drug discovery and development to the company, including a focus on development of therapeutics for metabolic disorders and in the identification and evaluation of <b>emerging technologies</b>. "Dr. Moller's experience provides an ideal fit for the Sigilon ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here